SlideShare a Scribd company logo
Vaccines –Production And
Application
Sana Shaikh
MSc – I; sem - I
Department Of Biochemistry
Institute Of Science

13.09.2013

1
Index
Slide no

Topics

3

Vaccine – An Introduction

4

Vaccine – History

5

Vaccine - Production

7

Application Of vaccine- Measels Vaccine

8

Application Of Vaccine- Polio Vaccine

9

Application Of Vaccine- Typhoid Vaccine

10

Application Of Vaccine- Hepatites B Vaccine

11

Application Of Vaccine- Tetenus Vaccine

12

Current Research

14

Refernces

13.09.2013

2
Vaccines –
An Introduction
• A vaccine is a biological preparation that improves immunity to a
particular disease.
• The term vaccine derives from Edward Jenner's 1796 use of cow
pox to inoculate humans, providing them protection against smallpox
• Vaccines may be prophylactic or therapeutic .
• Vaccines are killed, attenuated,toxoid, protein subunit or conjugate.
• Vaccines do not guarantee complete protection from a disease.

13.09.2013

3
History

Edward
Jenner

Louis
Pasteur
13.09.2013

• Prior to
vaccination, inoculation was
practised.
• In 1796, Jenner took pus from
the hand of a milkmaid with
cowpox, inoculated an 8-year-old
boy with it, and six weeks
later variolated the boy's arm with
smallpox, afterwards observing
that the boy did not catch
smallpox.
• It was banned in 1840 Louis
Pasteur generalized Jenner's idea
by developing what he called
a rabies vaccine
• The twentieth century saw the
introduction of several successful
vaccines

4
Production
Vaccines are produced in large scale as they need to be administered to
large populations of children and adults to be effective as a public
health tool. This large scale production is often a challenge.

Stages of vaccine production
Vaccine production has several stages. Process of vaccine
manufacture has the following steps:
Inactivation – This involves making of the antigen preparation
Purification – The isolated antigen is purified
Formulation – The purified antigen is combined with adjuvants,
stabilizers and preservatives to form the final vaccine
preparation.

13.09.2013

5
Applications
Vaccines have been used to prevent many
disease.Now for almost all the disease .
We would be considering Vaccines for
Measles, Poliomyelitis,Typhoid,
Hepatitis B, anti –tetanus.

13.09.2013

6
Measels Vaccine
• Measles vaccine is a highly effective vaccine used against measles.
• The measles-mumps-rubella-varicella combo (MMRV vaccine)
vaccine has been available since 2005
• Measles is rarely given as individual vaccine nowadays and is often
given in combination with mumps and rubella. Two types of vaccines
are available for measles currently.
• Mumps Measles Rubella vaccine, live (MMR-II)
• Mumps Measles Rubella and varicella virus vaccine.
Dose Schedule
1st dose at the age of 12 months
2nd dose at the age of four to six years

13.09.2013

7
Polio Vaccine
Two polio vaccines are used throughout the world to
combat poliomyelitis;
1.
An injected dose of inactivated poliovirus (IPV), is based on three
wild, virulent reference strains, Mahoney (type 1 poliovirus), MEF1 (type 2 poliovirus), and Saukett (type 3 poliovirus)
2. An oral vaccine was developed by using attenuated poliovirus
produced by the passage of the virus through non-human
cellThe vaccine contains small traceof antibiotics neomycin
and vaccine. A single dose of oral polio vaccine (usually
two drops) contains
1,000,000 infectious units of Sabin 1
(effective against PV1),
100,000 infectious units of the Sabin 2 strain, and
600,000 infectious units of Sabin 3
Dose schedule
OPV at birth, OPV and IPV at 6, 10 and 14 weeks. OPV and IPV at 15-18
months and OPV at 5 years.
13.09.2013

8
Typhoid vaccine
Enteric fever (typhoid and paratyphoid) is a major public health problem in India.
High prevalence of antimicrobial resistance particularly to quinolones has made
enteric feva difficult disease to treat. All these factors have made vaccines
against typhoid and paratyphoid fever of immense need in our country
There are two effective types:
• Ty21a, which is a live vaccine given orally
• Vi capsular polysaccharide vaccine, which is an injectable subunit vaccine
• Ty21a is licensed for use from age six years and older.
Dose Schedule
Boosters are recommended every 5 years. The Vi capsular polysaccharide vaccine is
licensed for use from age two years and older, and boosters are required every three
years

13.09.2013

9
Hepatites B
• In India, 1-4% of individuals are chronic carriers of Hepatitis B Virus (HBV)
• Younger the age of acquisition of HBV infection,
higher the chances of becoming
chronic carrier.
• Infection with HBV is one of the most
important causes of chronic hepatitis,
cirrhosis of liver and hepatocellular carcinoma
• Hepatitis B Immunoglobulin (HBIG)
HBIG provides passive immunity and is indicated along with Hep B vaccine in
management of perinatal/occupational/sexual exposures to Hepatitis B in
susceptible individuals.
• Dose Schedule
a. Birth, 1 and 6 months
b. Birth, 6 and 14 weeks
c. 6, 10 and 14 weeks
13.09.2013

10
Tetanus vaccines
• Tetanus infection is most often the result of wound contamination in an
unimmunized person or someone who has not had vaccine boosters in many years.
• It may also occur following puncture wounds, animal bites, burns, abrasions
and surgery.
• The tetanus toxin causes severe muscle contractions, or spasms.
• The tetanus vaccine is available as:
 DT or Td (in combination with Diphtheria vaccine)
 TT in wound management
 TT in pregnancy
• Dose Schedule
For children who are completely unimmunized, catch up vaccination should be provided by
giving three doses of TT at 0, 1 and 6 months. For partially immunized children catch up
vaccination entails administration of at least 3 doses of TT including previous doses
received. DT for catch up vaccination in those aged above 7 years
13.09.2013

11
Current research
Research:-P1-S6.44 HIV vaccine clinical trial adherence and
retention: high-risk drug-using women
Authors:-J Becher, S Chhatre, M Eisenberg, D Fiore, T
Dominique, D Dunbar, I Frank, D Metzger
Source:-Sex Transm Infect 2011;87:A214 doi:10.1136/sextrans2011-050108.268
Date:-Jul 2011

13.09.2013

12
Abstract
•

•

Background Clinical trial protocol adherence and retention are often considered
challenges that are especially difficult to achieve among certain high-risk populations. The
HIV infection rate among heterosexual African-American women is increasing, making their
participation in clinical trials of HIV behavioural and biomedical prevention interventions
more important. We identify drug use and sex risk factors associated with adherence to
protocol and study retention among this population during the course of an HIV vaccine
trial.
Conclusions Factors commonly assumed to interfere with trial participation were not
associated with adherence to study protocol or retention. These findings suggest that drug
use and sexual risk behaviours do not impede completion of vaccinations and protocol
required visits in clinical trials of experimental HIV vaccines.

13.09.2013

13
Reference
• http://en.wikipedia.org/wiki/Vaccine
• http://www.vaccines.gov/who_and_when/index.html
• http://www.news-medical.net/health/Vaccine-Production.aspx
• http://www.greenmedinfo.com/Abstract Title:
Hepatitis B vaccine induces apoptotic death in Hepa1-6 cells.Abstract Author(s):
Heyam Hamza, Jianhua Cao, Xinyun Li, Changchun Li, Mengjin Zhu, Shuhong Zhao
 http://www.vaccineschedule.in
• ttp://www.immunizationinfo.org
• http://tav.sagepub.com/; Therapeutic Advances in Vaccines; May 2013 -

September

• http://sti.bmj.com/content/87/Sex Transm
Infect 2011;87:A214 doi:10.1136/sextrans-2011-050108.26

13.09.2013

14
13.09.2013

15

More Related Content

What's hot

Northern, southern and western blotting
Northern, southern and western blottingNorthern, southern and western blotting
Northern, southern and western blotting
Ravi Kant Agrawal
 
DNA Vaccine
DNA VaccineDNA Vaccine
DNA Vaccine
Oyshe Ahmed
 
Vaccine production
Vaccine productionVaccine production
Vaccine production
Shweta Tiwari
 
Cell lines
Cell linesCell lines
P uc vectors
P uc vectorsP uc vectors
Vectors in biotechnolgy
Vectors in biotechnolgyVectors in biotechnolgy
Vectors in biotechnolgy
Kiran Kumar Mishra
 
Vaccine production techniques
Vaccine production techniquesVaccine production techniques
Vaccine production techniques
Dr Vijayata choudhary
 
VIRAL VECTORS FOR GENE TRANSFER
VIRAL VECTORS FOR GENE TRANSFERVIRAL VECTORS FOR GENE TRANSFER
VIRAL VECTORS FOR GENE TRANSFER
ANKUR SHARMA
 
Viral vector
Viral vectorViral vector
Viral vector
Cleopatra William
 
Hybridoma technology and production of monoclonal antibody
Hybridoma technology and production of monoclonal antibodyHybridoma technology and production of monoclonal antibody
Hybridoma technology and production of monoclonal antibody
Rajpal Choudhary
 
P br322
P br322P br322
Monoclonal antibodies production
Monoclonal antibodies productionMonoclonal antibodies production
Monoclonal antibodies production
sworna kumari chithiraivelu
 
Western blotting
Western blottingWestern blotting
Western blotting
microbiology Notes
 
Animal cell culture media
Animal cell culture mediaAnimal cell culture media
Animal cell culture media
Pankaj Nerkar
 
Monoclonal antibodies & hybridoma technology
Monoclonal antibodies & hybridoma technologyMonoclonal antibodies & hybridoma technology
Monoclonal antibodies & hybridoma technology
Ajay Dominic
 
SYNTHETIC PEPTIDE VACCINES AND RECOMBINANT ANTIGEN VACCINE
SYNTHETIC PEPTIDE  VACCINES  AND RECOMBINANT  ANTIGEN VACCINESYNTHETIC PEPTIDE  VACCINES  AND RECOMBINANT  ANTIGEN VACCINE
SYNTHETIC PEPTIDE VACCINES AND RECOMBINANT ANTIGEN VACCINE
D.R. Chandravanshi
 
Cloning vectors
Cloning vectorsCloning vectors
Cloning vectors
Ravi Kant Agrawal
 
Synthetic peptide vaccines.pptx
Synthetic peptide vaccines.pptxSynthetic peptide vaccines.pptx
Synthetic peptide vaccines.pptx
Anshulvishwakarma10
 
Interferon
InterferonInterferon
Interferon
Dr. Waqas Nawaz
 

What's hot (20)

Northern, southern and western blotting
Northern, southern and western blottingNorthern, southern and western blotting
Northern, southern and western blotting
 
DNA Vaccine
DNA VaccineDNA Vaccine
DNA Vaccine
 
Vaccine production
Vaccine productionVaccine production
Vaccine production
 
Cell lines
Cell linesCell lines
Cell lines
 
P uc vectors
P uc vectorsP uc vectors
P uc vectors
 
Vectors in biotechnolgy
Vectors in biotechnolgyVectors in biotechnolgy
Vectors in biotechnolgy
 
Vaccine production techniques
Vaccine production techniquesVaccine production techniques
Vaccine production techniques
 
VIRAL VECTORS FOR GENE TRANSFER
VIRAL VECTORS FOR GENE TRANSFERVIRAL VECTORS FOR GENE TRANSFER
VIRAL VECTORS FOR GENE TRANSFER
 
Viral vector
Viral vectorViral vector
Viral vector
 
Hybridoma technology and production of monoclonal antibody
Hybridoma technology and production of monoclonal antibodyHybridoma technology and production of monoclonal antibody
Hybridoma technology and production of monoclonal antibody
 
P br322
P br322P br322
P br322
 
Monoclonal antibodies production
Monoclonal antibodies productionMonoclonal antibodies production
Monoclonal antibodies production
 
Western blotting
Western blottingWestern blotting
Western blotting
 
Animal cell culture media
Animal cell culture mediaAnimal cell culture media
Animal cell culture media
 
Dna ligase
Dna ligaseDna ligase
Dna ligase
 
Monoclonal antibodies & hybridoma technology
Monoclonal antibodies & hybridoma technologyMonoclonal antibodies & hybridoma technology
Monoclonal antibodies & hybridoma technology
 
SYNTHETIC PEPTIDE VACCINES AND RECOMBINANT ANTIGEN VACCINE
SYNTHETIC PEPTIDE  VACCINES  AND RECOMBINANT  ANTIGEN VACCINESYNTHETIC PEPTIDE  VACCINES  AND RECOMBINANT  ANTIGEN VACCINE
SYNTHETIC PEPTIDE VACCINES AND RECOMBINANT ANTIGEN VACCINE
 
Cloning vectors
Cloning vectorsCloning vectors
Cloning vectors
 
Synthetic peptide vaccines.pptx
Synthetic peptide vaccines.pptxSynthetic peptide vaccines.pptx
Synthetic peptide vaccines.pptx
 
Interferon
InterferonInterferon
Interferon
 

Viewers also liked

Vaccine production
Vaccine productionVaccine production
Vaccine production
Dr. sreeremya S
 
Vaccine Production
Vaccine ProductionVaccine Production
Vaccine Production
ZainabSaif
 
5. vaccine technology
5. vaccine technology5. vaccine technology
5. vaccine technologyBruno Mmassy
 
VACCINE TECHNOLOGY
VACCINE TECHNOLOGYVACCINE TECHNOLOGY
VACCINE TECHNOLOGY
ADAM S
 
Vaccination ppt
Vaccination pptVaccination ppt
Vaccination ppt
ali7070
 
Vaccines,types,composition & failure etc
Vaccines,types,composition & failure etcVaccines,types,composition & failure etc
Vaccines,types,composition & failure etc
Dr. Waqas Nawaz
 
Conventional methods of animal vaccine production
Conventional methods of animal vaccine productionConventional methods of animal vaccine production
Conventional methods of animal vaccine production
Dr Vijayata choudhary
 
Vaccine & Its Type
Vaccine & Its TypeVaccine & Its Type
Vaccine & Its Type
Chhabi Acharya
 
Biotech Vaccine School
Biotech Vaccine SchoolBiotech Vaccine School
Biotech Vaccine Schoolspicyice123
 
Vaccines
VaccinesVaccines
Vaccines
HadeelSalah
 
Monoclonal antibody
Monoclonal antibodyMonoclonal antibody
Monoclonal antibody
Dr. Ashutosh Tiwari
 
Immunization
ImmunizationImmunization
Immunization
philoarnold
 
Dsp of vaccine
Dsp of vaccineDsp of vaccine
Dsp of vaccine
Niyamat Panjesha
 
Biosecurity
BiosecurityBiosecurity
Thu y c3. bệnh lợn gạo
Thu y   c3. bệnh lợn gạoThu y   c3. bệnh lợn gạo
Thu y c3. bệnh lợn gạoSinhKy-HaNam
 

Viewers also liked (20)

Vaccine production
Vaccine productionVaccine production
Vaccine production
 
Vaccine Production
Vaccine ProductionVaccine Production
Vaccine Production
 
5. vaccine technology
5. vaccine technology5. vaccine technology
5. vaccine technology
 
VACCINE TECHNOLOGY
VACCINE TECHNOLOGYVACCINE TECHNOLOGY
VACCINE TECHNOLOGY
 
Vaccines
VaccinesVaccines
Vaccines
 
Vaccination ppt
Vaccination pptVaccination ppt
Vaccination ppt
 
Vaccine
VaccineVaccine
Vaccine
 
Vaccines,types,composition & failure etc
Vaccines,types,composition & failure etcVaccines,types,composition & failure etc
Vaccines,types,composition & failure etc
 
Conventional methods of animal vaccine production
Conventional methods of animal vaccine productionConventional methods of animal vaccine production
Conventional methods of animal vaccine production
 
Vaccine & Its Type
Vaccine & Its TypeVaccine & Its Type
Vaccine & Its Type
 
Vaccine delivery
Vaccine deliveryVaccine delivery
Vaccine delivery
 
Biotech Vaccine School
Biotech Vaccine SchoolBiotech Vaccine School
Biotech Vaccine School
 
Vaccines
VaccinesVaccines
Vaccines
 
Monoclonal antibody
Monoclonal antibodyMonoclonal antibody
Monoclonal antibody
 
Immunization
ImmunizationImmunization
Immunization
 
Dsp of vaccine
Dsp of vaccineDsp of vaccine
Dsp of vaccine
 
Vaccination
VaccinationVaccination
Vaccination
 
Biosecurity
BiosecurityBiosecurity
Biosecurity
 
Thu y c3. bệnh lợn gạo
Thu y   c3. bệnh lợn gạoThu y   c3. bệnh lợn gạo
Thu y c3. bệnh lợn gạo
 
Prrs
PrrsPrrs
Prrs
 

Similar to Vaccines –production and application

Immunisatiion during pregnancy and post partum period
Immunisatiion during pregnancy and  post partum  periodImmunisatiion during pregnancy and  post partum  period
Immunisatiion during pregnancy and post partum period
Shivamurthy Hm
 
PEDIATRIC IMMUNIZATIONS A COMPLETE GUIDE FOR VACCINATORS
PEDIATRIC IMMUNIZATIONS A COMPLETE GUIDE FOR VACCINATORSPEDIATRIC IMMUNIZATIONS A COMPLETE GUIDE FOR VACCINATORS
PEDIATRIC IMMUNIZATIONS A COMPLETE GUIDE FOR VACCINATORS
AjitkumarPulagurtha1
 
Handbook on adult_immunization_2009_(contents)
Handbook on adult_immunization_2009_(contents)Handbook on adult_immunization_2009_(contents)
Handbook on adult_immunization_2009_(contents)raissa_09
 
EPI - Copy.ppt
EPI - Copy.pptEPI - Copy.ppt
EPI - Copy.ppt
Sana Murtaza
 
Understanding the Essential Vaccines for Babies
Understanding the Essential Vaccines for BabiesUnderstanding the Essential Vaccines for Babies
Understanding the Essential Vaccines for Babies
nowmedical ltd
 
immunization dnm4 lesson 3.pptx
immunization                    dnm4 lesson 3.pptximmunization                    dnm4 lesson 3.pptx
immunization dnm4 lesson 3.pptx
AnthonyMatu1
 
power point vaccination during pregnancy3faa.ppt
power point  vaccination during pregnancy3faa.pptpower point  vaccination during pregnancy3faa.ppt
power point vaccination during pregnancy3faa.ppt
IslamSaeed19
 
Vaccinations
VaccinationsVaccinations
Vaccinations
Amal Mohamed
 
Vaccine clinical trial
Vaccine clinical trialVaccine clinical trial
Vaccine clinical trialPiyush Bafna
 
VACCINATION IN PREGNANCY 25092023.pptx
VACCINATION IN PREGNANCY 25092023.pptxVACCINATION IN PREGNANCY 25092023.pptx
VACCINATION IN PREGNANCY 25092023.pptx
Niranjan Chavan
 
NIP PPT.pptx
NIP PPT.pptxNIP PPT.pptx
NIP PPT.pptx
JenEugenio2
 
Immunization-Program.pdf
Immunization-Program.pdfImmunization-Program.pdf
Immunization-Program.pdf
NicoleAnnePentecoste2
 
NIP PPT.pptx
NIP PPT.pptxNIP PPT.pptx
NIP PPT.pptx
JenEugenio2
 
Challenges of routine immunization services in nigeria
Challenges of routine immunization services in nigeriaChallenges of routine immunization services in nigeria
Challenges of routine immunization services in nigeria
Abiola Salami-Olubiyi
 
Designing vaccines for specific populations and germs - Slides by Professor E...
Designing vaccines for specific populations and germs - Slides by Professor E...Designing vaccines for specific populations and germs - Slides by Professor E...
Designing vaccines for specific populations and germs - Slides by Professor E...
WAidid
 
Universal Immunization Program
Universal Immunization ProgramUniversal Immunization Program
Universal Immunization Program
Priyanka Ch
 
Al Muktadir hussain biology project on immunisation
Al Muktadir hussain biology project on immunisationAl Muktadir hussain biology project on immunisation
Al Muktadir hussain biology project on immunisation
Al Muktadir Hussain
 
Adultvaccinationy 121010201616-phpapp02
Adultvaccinationy 121010201616-phpapp02Adultvaccinationy 121010201616-phpapp02
Adultvaccinationy 121010201616-phpapp02
Amir Mahmoud
 
Pentavalent vaccine introduction in immunization programme in India
Pentavalent vaccine introduction in immunization programme in IndiaPentavalent vaccine introduction in immunization programme in India
Pentavalent vaccine introduction in immunization programme in India
Vikky3
 

Similar to Vaccines –production and application (20)

Immunisatiion during pregnancy and post partum period
Immunisatiion during pregnancy and  post partum  periodImmunisatiion during pregnancy and  post partum  period
Immunisatiion during pregnancy and post partum period
 
PEDIATRIC IMMUNIZATIONS A COMPLETE GUIDE FOR VACCINATORS
PEDIATRIC IMMUNIZATIONS A COMPLETE GUIDE FOR VACCINATORSPEDIATRIC IMMUNIZATIONS A COMPLETE GUIDE FOR VACCINATORS
PEDIATRIC IMMUNIZATIONS A COMPLETE GUIDE FOR VACCINATORS
 
Handbook on adult_immunization_2009_(contents)
Handbook on adult_immunization_2009_(contents)Handbook on adult_immunization_2009_(contents)
Handbook on adult_immunization_2009_(contents)
 
EPI - Copy.ppt
EPI - Copy.pptEPI - Copy.ppt
EPI - Copy.ppt
 
Understanding the Essential Vaccines for Babies
Understanding the Essential Vaccines for BabiesUnderstanding the Essential Vaccines for Babies
Understanding the Essential Vaccines for Babies
 
immunization dnm4 lesson 3.pptx
immunization                    dnm4 lesson 3.pptximmunization                    dnm4 lesson 3.pptx
immunization dnm4 lesson 3.pptx
 
Adult vaccination
Adult vaccinationAdult vaccination
Adult vaccination
 
power point vaccination during pregnancy3faa.ppt
power point  vaccination during pregnancy3faa.pptpower point  vaccination during pregnancy3faa.ppt
power point vaccination during pregnancy3faa.ppt
 
Vaccinations
VaccinationsVaccinations
Vaccinations
 
Vaccine clinical trial
Vaccine clinical trialVaccine clinical trial
Vaccine clinical trial
 
VACCINATION IN PREGNANCY 25092023.pptx
VACCINATION IN PREGNANCY 25092023.pptxVACCINATION IN PREGNANCY 25092023.pptx
VACCINATION IN PREGNANCY 25092023.pptx
 
NIP PPT.pptx
NIP PPT.pptxNIP PPT.pptx
NIP PPT.pptx
 
Immunization-Program.pdf
Immunization-Program.pdfImmunization-Program.pdf
Immunization-Program.pdf
 
NIP PPT.pptx
NIP PPT.pptxNIP PPT.pptx
NIP PPT.pptx
 
Challenges of routine immunization services in nigeria
Challenges of routine immunization services in nigeriaChallenges of routine immunization services in nigeria
Challenges of routine immunization services in nigeria
 
Designing vaccines for specific populations and germs - Slides by Professor E...
Designing vaccines for specific populations and germs - Slides by Professor E...Designing vaccines for specific populations and germs - Slides by Professor E...
Designing vaccines for specific populations and germs - Slides by Professor E...
 
Universal Immunization Program
Universal Immunization ProgramUniversal Immunization Program
Universal Immunization Program
 
Al Muktadir hussain biology project on immunisation
Al Muktadir hussain biology project on immunisationAl Muktadir hussain biology project on immunisation
Al Muktadir hussain biology project on immunisation
 
Adultvaccinationy 121010201616-phpapp02
Adultvaccinationy 121010201616-phpapp02Adultvaccinationy 121010201616-phpapp02
Adultvaccinationy 121010201616-phpapp02
 
Pentavalent vaccine introduction in immunization programme in India
Pentavalent vaccine introduction in immunization programme in IndiaPentavalent vaccine introduction in immunization programme in India
Pentavalent vaccine introduction in immunization programme in India
 

Recently uploaded

Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
GeoBlogs
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
Celine George
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
Nguyen Thanh Tu Collection
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
PedroFerreira53928
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
AzmatAli747758
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
Steve Thomason
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
rosedainty
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
Fundacja Rozwoju Społeczeństwa Przedsiębiorczego
 

Recently uploaded (20)

Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
 

Vaccines –production and application

  • 1. Vaccines –Production And Application Sana Shaikh MSc – I; sem - I Department Of Biochemistry Institute Of Science 13.09.2013 1
  • 2. Index Slide no Topics 3 Vaccine – An Introduction 4 Vaccine – History 5 Vaccine - Production 7 Application Of vaccine- Measels Vaccine 8 Application Of Vaccine- Polio Vaccine 9 Application Of Vaccine- Typhoid Vaccine 10 Application Of Vaccine- Hepatites B Vaccine 11 Application Of Vaccine- Tetenus Vaccine 12 Current Research 14 Refernces 13.09.2013 2
  • 3. Vaccines – An Introduction • A vaccine is a biological preparation that improves immunity to a particular disease. • The term vaccine derives from Edward Jenner's 1796 use of cow pox to inoculate humans, providing them protection against smallpox • Vaccines may be prophylactic or therapeutic . • Vaccines are killed, attenuated,toxoid, protein subunit or conjugate. • Vaccines do not guarantee complete protection from a disease. 13.09.2013 3
  • 4. History Edward Jenner Louis Pasteur 13.09.2013 • Prior to vaccination, inoculation was practised. • In 1796, Jenner took pus from the hand of a milkmaid with cowpox, inoculated an 8-year-old boy with it, and six weeks later variolated the boy's arm with smallpox, afterwards observing that the boy did not catch smallpox. • It was banned in 1840 Louis Pasteur generalized Jenner's idea by developing what he called a rabies vaccine • The twentieth century saw the introduction of several successful vaccines 4
  • 5. Production Vaccines are produced in large scale as they need to be administered to large populations of children and adults to be effective as a public health tool. This large scale production is often a challenge. Stages of vaccine production Vaccine production has several stages. Process of vaccine manufacture has the following steps: Inactivation – This involves making of the antigen preparation Purification – The isolated antigen is purified Formulation – The purified antigen is combined with adjuvants, stabilizers and preservatives to form the final vaccine preparation. 13.09.2013 5
  • 6. Applications Vaccines have been used to prevent many disease.Now for almost all the disease . We would be considering Vaccines for Measles, Poliomyelitis,Typhoid, Hepatitis B, anti –tetanus. 13.09.2013 6
  • 7. Measels Vaccine • Measles vaccine is a highly effective vaccine used against measles. • The measles-mumps-rubella-varicella combo (MMRV vaccine) vaccine has been available since 2005 • Measles is rarely given as individual vaccine nowadays and is often given in combination with mumps and rubella. Two types of vaccines are available for measles currently. • Mumps Measles Rubella vaccine, live (MMR-II) • Mumps Measles Rubella and varicella virus vaccine. Dose Schedule 1st dose at the age of 12 months 2nd dose at the age of four to six years 13.09.2013 7
  • 8. Polio Vaccine Two polio vaccines are used throughout the world to combat poliomyelitis; 1. An injected dose of inactivated poliovirus (IPV), is based on three wild, virulent reference strains, Mahoney (type 1 poliovirus), MEF1 (type 2 poliovirus), and Saukett (type 3 poliovirus) 2. An oral vaccine was developed by using attenuated poliovirus produced by the passage of the virus through non-human cellThe vaccine contains small traceof antibiotics neomycin and vaccine. A single dose of oral polio vaccine (usually two drops) contains 1,000,000 infectious units of Sabin 1 (effective against PV1), 100,000 infectious units of the Sabin 2 strain, and 600,000 infectious units of Sabin 3 Dose schedule OPV at birth, OPV and IPV at 6, 10 and 14 weeks. OPV and IPV at 15-18 months and OPV at 5 years. 13.09.2013 8
  • 9. Typhoid vaccine Enteric fever (typhoid and paratyphoid) is a major public health problem in India. High prevalence of antimicrobial resistance particularly to quinolones has made enteric feva difficult disease to treat. All these factors have made vaccines against typhoid and paratyphoid fever of immense need in our country There are two effective types: • Ty21a, which is a live vaccine given orally • Vi capsular polysaccharide vaccine, which is an injectable subunit vaccine • Ty21a is licensed for use from age six years and older. Dose Schedule Boosters are recommended every 5 years. The Vi capsular polysaccharide vaccine is licensed for use from age two years and older, and boosters are required every three years 13.09.2013 9
  • 10. Hepatites B • In India, 1-4% of individuals are chronic carriers of Hepatitis B Virus (HBV) • Younger the age of acquisition of HBV infection, higher the chances of becoming chronic carrier. • Infection with HBV is one of the most important causes of chronic hepatitis, cirrhosis of liver and hepatocellular carcinoma • Hepatitis B Immunoglobulin (HBIG) HBIG provides passive immunity and is indicated along with Hep B vaccine in management of perinatal/occupational/sexual exposures to Hepatitis B in susceptible individuals. • Dose Schedule a. Birth, 1 and 6 months b. Birth, 6 and 14 weeks c. 6, 10 and 14 weeks 13.09.2013 10
  • 11. Tetanus vaccines • Tetanus infection is most often the result of wound contamination in an unimmunized person or someone who has not had vaccine boosters in many years. • It may also occur following puncture wounds, animal bites, burns, abrasions and surgery. • The tetanus toxin causes severe muscle contractions, or spasms. • The tetanus vaccine is available as:  DT or Td (in combination with Diphtheria vaccine)  TT in wound management  TT in pregnancy • Dose Schedule For children who are completely unimmunized, catch up vaccination should be provided by giving three doses of TT at 0, 1 and 6 months. For partially immunized children catch up vaccination entails administration of at least 3 doses of TT including previous doses received. DT for catch up vaccination in those aged above 7 years 13.09.2013 11
  • 12. Current research Research:-P1-S6.44 HIV vaccine clinical trial adherence and retention: high-risk drug-using women Authors:-J Becher, S Chhatre, M Eisenberg, D Fiore, T Dominique, D Dunbar, I Frank, D Metzger Source:-Sex Transm Infect 2011;87:A214 doi:10.1136/sextrans2011-050108.268 Date:-Jul 2011 13.09.2013 12
  • 13. Abstract • • Background Clinical trial protocol adherence and retention are often considered challenges that are especially difficult to achieve among certain high-risk populations. The HIV infection rate among heterosexual African-American women is increasing, making their participation in clinical trials of HIV behavioural and biomedical prevention interventions more important. We identify drug use and sex risk factors associated with adherence to protocol and study retention among this population during the course of an HIV vaccine trial. Conclusions Factors commonly assumed to interfere with trial participation were not associated with adherence to study protocol or retention. These findings suggest that drug use and sexual risk behaviours do not impede completion of vaccinations and protocol required visits in clinical trials of experimental HIV vaccines. 13.09.2013 13
  • 14. Reference • http://en.wikipedia.org/wiki/Vaccine • http://www.vaccines.gov/who_and_when/index.html • http://www.news-medical.net/health/Vaccine-Production.aspx • http://www.greenmedinfo.com/Abstract Title: Hepatitis B vaccine induces apoptotic death in Hepa1-6 cells.Abstract Author(s): Heyam Hamza, Jianhua Cao, Xinyun Li, Changchun Li, Mengjin Zhu, Shuhong Zhao  http://www.vaccineschedule.in • ttp://www.immunizationinfo.org • http://tav.sagepub.com/; Therapeutic Advances in Vaccines; May 2013 - September • http://sti.bmj.com/content/87/Sex Transm Infect 2011;87:A214 doi:10.1136/sextrans-2011-050108.26 13.09.2013 14